Vision impairment that’s easy to fix in rich countries can be life sentences in most of the world. These volunteer docs aim to change that. (Read about Orbis on Fast Company.)… Read the rest
For about $1,000, companies can read your DNA, but not without mistakes. The U.S. government is trying to help them do a better job of it. (Read about genetic testing on Fast Company.)… Read the rest
You can get your entire genetic code deciphered for about $1,000 in a day, but scientists still don’t know what most of it means. (Read more about uncertainty of genetic results on Fast Company.)… Read the rest
Curing both rare diseases and common cancers doesn’t just require new research, but also linking all the data that researchers already have. (Read more about the Cancer Moonshot on Fast Company.)… Read the rest
Key players agree that cancer cures are within reach. Two major, sometimes overlapping, efforts are underway—one public and one private. (Read about the cancer moonshots on Fast Company.)… Read the rest
Use of artificial intelligence in health care to grow tenfold in 5 years, say analysts—for everything from cancer diagnosis to diet tips. (Read more about AI in healthcare on Fast Company.)… Read the rest
Glide is far from the first video-chat service: Skype was founded a dozen years ago, and FaceTime debuted on the iPhone 4 in 2010. And of course Snapchat has video. But Glide has one killer feature for deaf people: the ability to leave a video message rather than having to prearrange a live call.… Read the rest
For people with obscure conditions, sometimes called mystery diseases, UDP has been a last resort that combines weeklong medical examinations, genetic sequencing, and data analysis in an effort to finally find a diagnosis and treatment for patients who are at wit’s end.… Read the rest
[Fast Company, Photo: Flickr user A Silly Person] My Retina Tracker hooks patients with a big, though long-shot, incentive: By uploading their medical records and answering questionnaires, patients may get the attention of researchers who may be doing clinical trials for treating their disease.… Read the rest
